Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study

Purpose: To examine the safety of a single intravitreal injection of autologous bone Marrow Mesenchymal stem cells (MSCs) in patients with advanced retinitis pigmentosa (RP). Methods: A prospective, phase I, nonrandomized, open-label study was conducted on 3 eyes of 3 volunteers with advanced RP. Vi...

Full description

Bibliographic Details
Main Authors: Leila Satarian, Ramin Nourinia, Sare Safi, Mozhgan Rezaei Kanavi, Neda Jarughi, Narsis Daftarian, Leila Arab, Nasser Aghdami, Hamid Ahmadieh, Hossein Baharvand
Format: Article
Language:English
Published: Knowledge E 2017-01-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Online Access:http://www.jovr.org/article.asp?issn=2008-322X;year=2017;volume=12;issue=1;spage=58;epage=64;aulast=Satarian
_version_ 1797990300502720512
author Leila Satarian
Ramin Nourinia
Sare Safi
Mozhgan Rezaei Kanavi
Neda Jarughi
Narsis Daftarian
Leila Arab
Nasser Aghdami
Hamid Ahmadieh
Hossein Baharvand
author_facet Leila Satarian
Ramin Nourinia
Sare Safi
Mozhgan Rezaei Kanavi
Neda Jarughi
Narsis Daftarian
Leila Arab
Nasser Aghdami
Hamid Ahmadieh
Hossein Baharvand
author_sort Leila Satarian
collection DOAJ
description Purpose: To examine the safety of a single intravitreal injection of autologous bone Marrow Mesenchymal stem cells (MSCs) in patients with advanced retinitis pigmentosa (RP). Methods: A prospective, phase I, nonrandomized, open-label study was conducted on 3 eyes of 3 volunteers with advanced RP. Visual acuity, slit-lamp examination, fundus examination, optical coherence tomography, fundus auto-fluorescence, fluorescein angiography and multifocal electroretinography were performed before and after an intravitreal injection of approximately one-million MSCs. The patients were followed for one year. Further evaluation of MSCs was performed by injection of these cells into the mouse vitreous cavity. Results: No, adverse events were observed in eyes of 2 out of 3 patients after transplantation of MSCs. These patients reported improvements in perception of the light after two weeks, which lasted for 3 months. However, severe fibrous tissue proliferation was observed in the vitreous cavity and retrolental space of the third patient's eye, which led to tractional retinal detachment (TRD), iris neovascularization and formation of mature cataract. Injection of this patient's MSCs into the vitreous cavity of mice also resulted in fibrosis; however, intravitreal injections of the two other patients' cells into the mouse vitreous did not generate any fibrous tissue. Conclusion: Intravitreal injection of autologous bone marrow MSCs into patients' eyes with advanced RP does not meet safety standards. Major side effects of this therapy can include fibrosis and TRD. We propose thorough evaluation of MSCs prior to transplantation by intravitreal injection in the laboratory animals.\
first_indexed 2024-04-11T08:34:18Z
format Article
id doaj.art-678f00878bc7493dbac343ac64f4ca71
institution Directory Open Access Journal
issn 2008-322X
language English
last_indexed 2024-04-11T08:34:18Z
publishDate 2017-01-01
publisher Knowledge E
record_format Article
series Journal of Ophthalmic & Vision Research
spelling doaj.art-678f00878bc7493dbac343ac64f4ca712022-12-22T04:34:23ZengKnowledge EJournal of Ophthalmic & Vision Research2008-322X2017-01-01121586410.4103/2008-322X.200164Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety studyLeila SatarianRamin NouriniaSare SafiMozhgan Rezaei KanaviNeda JarughiNarsis DaftarianLeila ArabNasser AghdamiHamid AhmadiehHossein BaharvandPurpose: To examine the safety of a single intravitreal injection of autologous bone Marrow Mesenchymal stem cells (MSCs) in patients with advanced retinitis pigmentosa (RP). Methods: A prospective, phase I, nonrandomized, open-label study was conducted on 3 eyes of 3 volunteers with advanced RP. Visual acuity, slit-lamp examination, fundus examination, optical coherence tomography, fundus auto-fluorescence, fluorescein angiography and multifocal electroretinography were performed before and after an intravitreal injection of approximately one-million MSCs. The patients were followed for one year. Further evaluation of MSCs was performed by injection of these cells into the mouse vitreous cavity. Results: No, adverse events were observed in eyes of 2 out of 3 patients after transplantation of MSCs. These patients reported improvements in perception of the light after two weeks, which lasted for 3 months. However, severe fibrous tissue proliferation was observed in the vitreous cavity and retrolental space of the third patient's eye, which led to tractional retinal detachment (TRD), iris neovascularization and formation of mature cataract. Injection of this patient's MSCs into the vitreous cavity of mice also resulted in fibrosis; however, intravitreal injections of the two other patients' cells into the mouse vitreous did not generate any fibrous tissue. Conclusion: Intravitreal injection of autologous bone marrow MSCs into patients' eyes with advanced RP does not meet safety standards. Major side effects of this therapy can include fibrosis and TRD. We propose thorough evaluation of MSCs prior to transplantation by intravitreal injection in the laboratory animals.\http://www.jovr.org/article.asp?issn=2008-322X;year=2017;volume=12;issue=1;spage=58;epage=64;aulast=SatarianIntravitreal Injection; Mesenchymal Stem Cells; Retinitis Pigmentosa
spellingShingle Leila Satarian
Ramin Nourinia
Sare Safi
Mozhgan Rezaei Kanavi
Neda Jarughi
Narsis Daftarian
Leila Arab
Nasser Aghdami
Hamid Ahmadieh
Hossein Baharvand
Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study
Journal of Ophthalmic & Vision Research
Intravitreal Injection; Mesenchymal Stem Cells; Retinitis Pigmentosa
title Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study
title_full Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study
title_fullStr Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study
title_full_unstemmed Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study
title_short Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study
title_sort intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa a safety study
topic Intravitreal Injection; Mesenchymal Stem Cells; Retinitis Pigmentosa
url http://www.jovr.org/article.asp?issn=2008-322X;year=2017;volume=12;issue=1;spage=58;epage=64;aulast=Satarian
work_keys_str_mv AT leilasatarian intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy
AT raminnourinia intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy
AT saresafi intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy
AT mozhganrezaeikanavi intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy
AT nedajarughi intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy
AT narsisdaftarian intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy
AT leilaarab intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy
AT nasseraghdami intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy
AT hamidahmadieh intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy
AT hosseinbaharvand intravitrealinjectionofbonemarrowmesenchymalstemcellsinpatientswithadvancedretinitispigmentosaasafetystudy